(Q75344763)
English
Final results of the EORTC 18871/DKG 80-1 randomised phase III trial. rIFN-alpha2b versus rIFN-gamma versus ISCADOR M versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metast
scientific article published on 01 February 2004
Statements
Final results of the EORTC 18871/DKG 80-1 randomised phase III trial. rIFN-alpha2b versus rIFN-gamma versus ISCADOR M versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasis (English)
U R Kleeberg
S Suciu
E B Bröcker
D J Ruiter
C Chartier
D Liénard
J Marsden
D Schadendorf
A M M Eggermont
EORTC Melanoma Group in cooperation with the German Cancer Society (DKG)
1 February 2004